Date Palm Pollen Allergoid: Characterization of Its Chemical-Physical and Immunological PropertiesMistrello G. · Harfi H. · Roncarolo D. · Kwaasi A. · Zanoni D. · Falagiani P. · Panzani R.
aLofarma S.p.A., Milan, Italy; bNational Center of Allergy, Asthma and Immunology, Riyad, and cKing Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; dUniversity of Oxford, Botnar Research Centre, Oxford, UK; eCentre de Recherche en Allergologie, Marseille, France
Background: Date palm (DP) pollen can cause allergic symptoms in people living in different countries. Specific immunotherapy with allergenic extracts by subcutaneous route is effective to cure allergic people. However, the risk of side effects has led to explore safer therapeutic modalities. The aim of our work was to evaluate IgE cross-reactivity between DP and autochthonous palm (European fan palm, EFP) pollen extracts, to chemically modify DP extract with potassium cyanate in order to obtain an allergoid, and to characterize it. Methods: By radioallergosorbent test inhibition, immunoblotting (IB) and skin prick test, in vitro and in vivo allergenic activities of native and modified DP extracts were compared. By SDS-PAGE and IB, we compared the protein profile and IgE-binding capacity of both native and modified DP, as well as of EFP extracts. By IB inhibition, IgE cross-reactivity of native DP and EFP extracts was evaluated. By ELISA, the capacity of modified DP-induced IgG to react with native DP extract was determined. Results: Radioallergosorbent test inhibition, IB and skin prick test results demonstrated that modified DP was significantly less allergenic than native DP extract. The SDS-PAGE profile showed that potassium cyanate treatment of DP extract did not alter the molecular weight of its components. In addition, no difference was observed between native DP and EFP extracts. Subsequent IB inhibition data evidenced the existence of a strong IgE cross-reactivity between native DP and EFP extracts. ELISA results indicated that the administration of modified DP in mice was able to induce specific IgG also recognizing native DP extract. Conclusions: Modified DP extract (allergoid) seems to be a good candidate for immunotherapy of patients affected by specific allergy.
Correspondence to: Dr. Gianni Mistrello
Viale Cassala 40
IT–20143 Milan (Italy)
Tel. +39 02 5819 8225, Fax +39 02 5819 8302, E-Mail email@example.com
Received: November 13, 2006
Accepted after revision: June 18, 2007
Published online: October 3, 2007
Number of Print Pages : 7
Number of Figures : 4, Number of Tables : 0, Number of References : 44
International Archives of Allergy and Immunology
Vol. 145, No. 3, Year 2008 (Cover Date: February 2008)
Journal Editor: Valenta, R. (Vienna)
ISSN: 1018–2438 (Print), eISSN: 1423–0097 (Online)
For additional information: http://www.karger.com/IAA
|Direct payment||This item at the regular price: USD 38.00|
|Payment from account||With a Karger Pay-per-View account (down payment USD 150)
you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50